SCHEMBL18658463

SCHEMBL18658463

CCOC(=O)C1(C)CC2(CCC2)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.41
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
POLB P06746 1/20 0.39
BRD4 O60885 1/20 0.38
F10 P00742 4/20 0.37
PTPN2 P17706 1/20 0.35
PTPN1 P18031 1/20 0.35
CDC25B P30305 1/20 0.35
ALDH1A1 P00352 2/20 0.34
OPRM1 P35372 6/20 0.34
OPRD1 P41143 3/20 0.33
OPRK1 P41145 3/20 0.33
SLC22A1 O15245 1/20 0.33
SLC6A4 P31645 1/20 0.33
ADRA1A P35348 1/20 0.33
KCNH2 Q12809 1/20 0.33
LMNA P02545 1/20 0.33
HSD17B10 Q99714 1/20 0.33
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL265557 0.84 SMN1; SMN2 (0.45) SMN1; SMN2MEN1KMT2APOLBBRD4
SCHEMBL6736700 0.83 POLB (0.46) SMN1; SMN2MEN1KMT2APOLBBRD4
SCHEMBL15777072 0.82 SMN1; SMN2 (0.41) SMN1; SMN2MEN1KMT2APOLBF10
SCHEMBL17192238 0.81 SMN1; SMN2 (0.39) SMN1; SMN2MEN1KMT2APOLBF10
SCHEMBL2289941 0.81
SCHEMBL60903 0.79 BRD4 (0.41) SMN1; SMN2MEN1KMT2APOLBBRD4
SCHEMBL25299400 0.79 ATM (0.39) SMN1; SMN2MEN1KMT2APOLBBRD4
SCHEMBL19381503 0.78 SMN1; SMN2 (0.39) SMN1; SMN2MEN1KMT2APOLBF10
SCHEMBL16541489 0.78 BRD4 (0.41) SMN1; SMN2MEN1KMT2APOLBBRD4
SCHEMBL2287208 0.78 BRD4 (0.41) SMN1; SMN2MEN1KMT2APOLBBRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2928885-B1 MODULATORS OF THE RETINOID-RELATED ORPHAN RECEPTOR GAMMA (ROR-GAMMA) FOR USE IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES GLAXO GROUP LTD (GB) 2017-03-22 EP disclosed